Cytrx Biopool, Ltd.
Country not established
- Devices
- 1
What Cytrx Biopool, Ltd. makes
Cytrx Biopool, Ltd. manufactures the SPECTROLYSE/FIBRIN device, a diagnostic tool designed for analyzing fibrin properties in blood samples, likely used in coagulation studies or thrombus research.
The SPECTROLYSE/FIBRIN device is classified as a Class II medical device under FDA regulations and is listed in the FDA’s 510(k) clearance registry. The company is based in the United States.
Catalogue
Spectrolyse/Fibrin Ref K881037
510(k) 510(k)
Frequently asked questions
How many devices does Cytrx Biopool, Ltd. have in the registry?
The registry currently lists 1 device for Cytrx Biopool, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cytrx Biopool, Ltd.'s devices?
Among its 1 most recently registered device, Cytrx Biopool, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Cytrx Biopool, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Cytrx Biopool, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cytrx Biopool, Ltd. in the registry?
The most recently registered devices listed for Cytrx Biopool, Ltd. include SPECTROLYSE/FIBRIN.